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http://dxObjective: In an effort to expand the cardiac donor pool, we tested the hypothesis that hemoadsorption of
cytokines attenuates brain death–induced ventricular dysfunction.
Methods: Eighteen Yorkshire pigs (50-60 kg) were instrumented with a left ventricular conductance catheter.
Cytokine expression, preload recruitable stroke work, and the diastolic relaxation constant tau were measured at
baseline and at hourly intervals for 6 hours after induction of brain death by intracranial balloon inflation (brain
death, n¼ 6) or sham operation (control, n¼ 6). In a third group (brain deathþhemoadsorption, n¼ 6), 3 hours
after induction of brain death, animals were placed on an extracorporeal circuit containing a cytokine-
hemoadsorption device for the remaining 3 hours of the experiment. Myocardial water content was measured
after the animals were killed.
Results: Six hours after induction of brain death, tumor necrosis factor and interleukin-6 were highest in
the brain death group (106  13.1 pg/mL and 301  181 pg/mL, respectively), lowest in controls (68.3 
8.55 pg/mL and 37.8  11 pg/mL, respectively), and intermediate in the brain deathþhemoadsorption group
(81.2  35.2 pg/mL and 94.6  20 pg/mL, respectively). Compared with controls, preload recruitable
stroke work was significantly reduced in the brain death group 4 hours after the induction of brain death and
was 50% of baseline by 5 hours. In the brain deathþhemoadsorption group, preload recruitable stroke work
was relatively preserved at 80% of baseline at similar time points. Tau remained unchanged in the control
and brain deathþhemoadsorption groups, whereas in the brain death group it was significantly elevated versus
baseline 5 (139.3%  21.5%) and 6 (172%  16.1%) hours after induction of brain death. Myocardial water
content was significantly greater in the brain death group than in the other 2 groups.
Conclusions:Hemoadsorption of cytokines using an extracorporeal circuit attenuates brain death–induced ven-
tricular dysfunction in a porcine model. Improvement in function generally correlates with trends in cytokine
expression, but this relationship requires further investigation. (J Thorac Cardiovasc Surg 2013;145:215-24)T
XAlthough the majority of organs for solid-organ trans-
plants come from cadaveric donors, it has long been rec-
ognized that brain death pathophysiology presents
a hostile environment to organ function. Brain death has
been linked not only to impaired donor organ function,
an effect that is particularly pronounced in the heart,1
but also to primary graft dysfunction after transplantation2
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The Journal of Thoracic and Caincidence of both acute3 and chronic4 rejection leading
to worse long-term outcomes. Estimates suggest that
20% of potential donors are excluded from cardiac dona-
tion because of the adverse effect of brain death on heart
function.5 Inspired in part by previous studies that demon-
strated that this phenomenon could be reversed in an iso-
lated rat-heart model,6 we sought to rehabilitate hearts
damaged by the pathophysiology of brain death to expand
the donor pool.
Explanations for the mechanism of brain death–induced
ventricular dysfunction include ischemic injury,7 direct cat-
echolamine–induced myocardial injury,8 and impaired
ß-adrenergic receptor signaling.9 Although the phenome-
non is likely multifactorial, there is increasing evidence
that the surge in inflammatory cytokines that accompanies
brain death plays an important role. For example, exoge-
nous cytokine administration has been shown to cause
a dose-dependent, reversible injury to ventricular function
in both clinical10 and experimental settings.11 In addition,
tumor necrosis factor (TNF) and interleukin (IL)-6 expres-
sions have been shown to be greater in human hearts re-
jected for transplantation when compared with those
accepted for transplantation.12rdiovascular Surgery c Volume 145, Number 1 215
Abbreviations and Acronyms
dP/
dtmax
¼ left ventricular maximum change in
pressure with time
dP/
dtmin
¼ left ventricular minimum change in
pressure with time
HA ¼ hemoadsorption
IL ¼ interleukin
LV ¼ left ventricular
NGAL ¼ neutrophil gelatinase-associated lipocalin
PRSW ¼ preload recruitable stroke work
TNF ¼ tumor necrosis factor
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XHemoadsorption (HA) of cytokines using CytoSorb
(Cytosorbents Inc, Monmouth Junction, NJ), an
adsorption-based cytokine removal device, has been shown
to significantly reduce cytokine levels both in vitro13 and in
septic animals.14 In addition, the feasibility of HA in organ
donors has been demonstrated.15 Therefore, in an effort to
address the critical shortage of transplantable hearts, we de-
termined the effect of cytokine HA on brain death–induced
ventricular dysfunction.
MATERIALS AND METHODS
All experiments were approved by the University of Washington Insti-
tution for Animal Care and Use Committee and were in compliance with
the seventh update of the Guide for the Care and Use of Laboratory
Animals, prepared by the Institute of Laboratory Animal Resources and
published by the National Institutes of Health (publication no. 85-23,
revised 1996, www.nap.edu/catalog/5140.html).
Experimental Model
Domestic, male Yorkshire-Landrace pigs (n ¼ 18) (range, 50-60 kg)
were divided into 3 groups. Ventricular function, serum cytokine concen-
trations, and laboratory indices of pulmonary, renal, and hepatic function
were measured at baseline and at hourly intervals, for 6 hours, after induc-
tion of brain death (brain death, n ¼ 6) or sham operation (control, n ¼ 6).
In the third group (brain deathþHA, n¼ 6), 3 hours after induction of brain
death, animals were systemically heparinized and subjected to 3 hours of
an extracorporeal circuit containing the Cytosorb HA device. Six hours
after induction of brain death, hearts were arrested using antegrade crystal-
loid cardioplegia. Postmortem studies included determination of myocar-
dial water content and histologic stigmata of myocyte injury (Figure 1).
Surgical Preparation
Animals were premedicated using intramuscular telazol (2.0-8.0 mg/
kg) and xylazine (2.2-4.4 mg/kg). They were induced with 3% to 5% iso-
flurane by facemask, endotracheally intubated, maintained on 1% to 2%
isoflurane, and mechanically ventilated at an initial minute volume of
150 mL/kg. Adjustments in ventilation parameters were made on the basis
of arterial blood gases that were sent periodically to maintain a pH of 7.35
to 7.45 and a carbon dioxide tension 35 to 45 torr; the fraction of inspired
oxygen was kept at 1.0 throughout the experiment. Normothermia was
maintained using a Bair Hugger (Arizant Healthcare Inc, Eden Prairie,
Minn). Warmed normal saline was administered through an 18-gauge
angiocatheter in an ear vein at 30 mL/kg/h for the first hour and 10 mL/
kg/h for the duration of the study. Continuous monitoring included heart
rate, body temperature, respiratory rate, electrocardiogram, mean arterial216 The Journal of Thoracic and Cardiovascular Surgpressure, and electroencephalogram (Olympic Medical CFM 6000, San
Carlos, Calif). The animals were restrained in dorsal recumbency, and sur-
gical sites were clipped and cleaned with alternating alcohol and 7.5%
povidone-iodine solution. A median sternotomy was performed; the infe-
rior vena cava was encircled with umbilical tape. A 7F pressure-volume
conductance catheter (SciSense, London, Ontario) was placed through
the left ventricular (LV) apex.
Data Analysis
Electrocardiogram, heart rate, mean arterial pressure, cardiac output,
LV pressure, LV volume, and admittance were sampled at 200 Hz with
a 10-channel analog-to-digital converter (IX/228S Data Acquisition
System; iWorx Systems Inc, Dover, NH) and recorded on a computer (Mac-
Book Pro; Apple Computer, Inc, Cupertino, Calif). Instantaneous LV
volume was determined by measuring parallel conductance in real-time
using the method of Wei and colleagues.16 Pressure-volume loops were re-
corded during a transient cessation in ventilation during the steady-state
and inferior vena caval occlusions. Datawere analyzed using commercially
available software (LabScribe2, iWorx Systems Inc). Preload recruitable
stroke work (PRSW) was used as a load-independent index of contractil-
ity.17 The diastolic relaxation constant tau was calculated using the method
of Weiss and colleagues.18
Brain Death
A 14F Foley with a 30-mL balloon was inserted into the subdural space
through a burr-hole drilled in the left frontoparietal region as previously de-
scribed.19 The balloon was gradually inflated (1 mL/min) to 20 mL. Brain
death was confirmed by electroencephalographic quiescence and the
presence of fixed and dilated pupils. In sham-operated control animals,
the scalp was exposed but no catheter was inserted. In animals that became
markedly hypotensive in the hours after induction of brain death (mean ar-
terial pressure<40mmHg) unresponsive to volume administration, a bolus
of vasopressin (0.5 units) was given intravenously and repeated if necessary.
Hemoadsorption Procedure
Three hours after induction of brain death, animals in the brain deathþ
HA group were connected to an extracorporeal circuit using standard dial-
ysis tubing and a catheter (Arrow International, Reading, Pa) placed in the
femoral vein connected to a 300-mL CytoSorb cytokine-adsorption filter.
The active component of this device consists of adsorbent beads composed
of porous polymerized divinylbenzene. The pores are sized to remove mol-
ecules less than 50 kD, which is sufficient to remove almost all known cy-
tokines. A peristaltic pump (MasterFlex, Cole-Parmer, Vernon Hills, Ill)
was used in conjunction with the circuit. The tubing and filter were primed
using approximately 200 mL of normal saline. Animals were systemically
heparinized with 10,000 units of heparin; an additional 5000 units were
given every hour to maintain an activated clotting time of 1.5 times
baseline. Initial flow through the circuit was set at approximately
340 mL/min and adjusted depending on access pressures.
Histology and Myocardial Water Content
With the use of a number 11 blade, 2 full-thickness biopsies were taken
from the LV freewall of each heart just after arrest. One biopsy was fixed in
methyl Carnoy’s solution, routinely processed, and paraffin-embedded for
histologic studies (Histology and Imaging Core, University of Washington
Department of Comparative Medicine, Seattle, Wash). Five-micrometer
sections were stained with hematoxylin–eosin and Masson’s trichrome
and then evaluated by a blinded pathologist for stigmata of acute myocar-
dial injury, including glycogenolysis, wavy fibers, and contraction band
necrosis. All of the evaluated specimens had areas of myocardium without
abnormalities, indicating reasonable tissue preservation.
The other biopsy was blotted dry and weighed on a digital scale to de-
termine wet weight (WW); it was then dried in an oven for several days toery c January 2013
FIGURE 1. Schematic of experimental design. Dashed vertical line indicates initiation of cytokine hemoadsorption (HA) in the brain deathþHA group.
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Xa constant weight and reweighed to determine dry weight (DW). Myocar-
dial water content (MWC%) was calculated as follows:
MWC% ¼ ½ðWWDWÞ=WW3100
Biochemical Analyses
Blood samples were drawn into pyrogen-free vials, and plasmawas sep-
arated by centrifugation and frozen (80C). Serum concentrations of
cytokines (TNF, IL-6, and IL-10) were measured at baseline and at hourly
intervals for the duration of the experiment. Cytokine concentrations were
measured using commercially available enzyme-linked immunosorbent as-
say kits (R&D Systems, Minneapolis, Minn), thawing samples only once
before using. This assay uses the quantitative sandwich enzyme immuno-
assay technique. At baseline and at 3 and 6 hours after induction of brain
death, blood samples also were drawn to measure aspartate aminotransfer-
ase, alanine aminotransferase, blood urea nitrogen, and creatinine, and
analyzed by an on-site veterinary laboratory. Plasma neutrophil
gelatinase-associated lipocalin (NGAL), a protein expressed in neutrophils
and certain epithelia including renal tubules, was used as an early and sen-
sitive biomarker of renal injury20 using commercially available enzyme-
linked immunosorbent assay kits (BioPorto Diagnostics, Gentofte,
Denmark).
Statistical Analysis
Serial data over time within a group were analyzed with repeated-
measures analysis of variance, and post hoc comparisons were made using
the Dunnett test to compare mean values at each time point to baseline
values. For comparisons between groups at a given time point, we used
1-way analysis of variance with post hoc comparisons made by Bonferro-
ni’s method when appropriate. The primary analysis was the determination
of significant differences between groups at 6 hours after brain death (or
sham operation); we performed the same analysis at other time points
but did not adjust for multiple comparisons. When data did not pass the
Kolmogorov–Smirnov normality test for Gaussian distribution or if the
Bartlett’s test suggested that differences in standard deviations were signif-
icant, then the nonparametric Kruskal–Wallis test was used with Dunn’s
post hoc test where appropriate. Linear regression was performed to deter-
mine the correlation between cytokine expression and ventricular function.
The Fisher exact test was used to analyze the presence or absence of histo-
logic injury between groups. Analyses were conducted using GraphPad
Prism version 5 software (GraphPad Inc, La Jolla, Calif) by an independent
biostatistician.
RESULTS
Baseline Comparisons Between Groups
Therewere no significant differences in hemodynamics, in-
dices of ventricular function, or serum markers of renal, he-
patic, or pulmonary function at baseline (Tables 1 and 2).The Journal of Thoracic and CaThere were no significant differences in any of these parame-
ters between the 2 brain dead groups at the 3-hour mark, con-
firming that these groups were physiologically equivalent just
before the initiation of HA. One animal in the brain deathþ
HA group, approximately 30 minutes after initiating HA, be-
came severely hypotensive despite volume administration and
vasopressin; marked right ventricular distension developed,
leading to cardiac arrest. Postmortem examination demon-
strated diffuse bilateral atelectasis and thrombus formation
in both main pulmonary arteries; the animal was included in
the study on an intention-to-treat basis. Three animals in
each of the brain death groups required a vasopressin bolus
for hypotension unresponsive to volume resuscitation.
Effectiveness of Cytokine Hemoadsorption
Both TNF and IL-6 expression over time were highest in
the brain death group, lowest in the control group, and inter-
mediate in the brain deathþHA group (Figure 2, A and B).
This trend was statistically significant for TNF expression
beginning 5 hours after the induction of brain death. IL-
10 expression was detectable only in control animals in
the first half of the experiment, so we stopped measuring it.
Effect of Cytokine Hemoadsorption on Systolic Left
Ventricular Function
Systolic LV function as reflected by PRSW is demon-
strated by Figure 3, A. For control animals, PRSW was un-
changed for the duration of the experiment. In the brain
death group, PRSW was significantly reduced versus base-
line at 2 hours, whereas in the brain deathþHA group, this
took 3 hours to occur. After initiating cytokine HA, PRSW
leveled off at approximately 80% of baseline in the brain
deathþHA group, whereas the brain death group continued
to deteriorate: PRSW became significantly worse versus
controls at 4 hours after induction of brain death (67.11%
of baseline vs 105.81% of baseline, P ¼ .016). At both 5
and 6 hours, PRSW in the brain death group (50.09% and
49.79% of baseline, respectively) was significantly worse
than in both the control group (101.67% and 102.24% of
baseline, respectively) and the brain death þ HA group
(81.78% and 84.85% of baseline, respectively, P< .05).
LV maximum change in pressure with time (dP/dtmax),rdiovascular Surgery c Volume 145, Number 1 217
TABLE 1. Hemodynamics, ventricular function, and cytokine
concentration over time
Baseline
3 h after
brain death
6 h after
brain death
Heart rate (beats/min)
Control 82.0  4.6 80.0  3.4 89.1  5.0
Brain death 94.0  8.0 106  6.7* 101  11
Brain death + HA 76.0  1.6 96.0  8.0 111  11y
Cardiac output (mL/min)
Control 1732  355 2748  630y 2947  618y
Brain death 1807  150 2875  1060 1221  239*
Brain death + HA 1626  364 2427  710 1476  253
PRSW (mm Hg)
Control 50.78  6.9 51.06  5.6 51.28  6.7
Brain death 66.28  3.5 54.35  4.1 33.88  7.2z
Brain death + HA 62.57  6.5 49.05  5.9y 53.54  6.5
Tau (ms)
Control 36.7  4.2 34.3  3.0 36.2  3.5
Brain death 36.8  2.3 43.1  6.9 62.0  4.5y,z
Brain death + HA 41.1  2.9 38.4  4.3 37.8  2.7
dP/dtmax (mm Hg/s)
Control 787  72 786  94 754  36
Brain death 939  106 868  85 893  136
Brain death + HA 831  81 790  115 1050  216
dP/dtmin (mm Hg/s)
Control 1110  66 1158  107 1070  89
Brain death 1294  115 910  62y 545  95y,z
Brain death + HA 1307  173 920  114 1077  350
Ejection fraction (%)
Control 32  4 39  6 35  4
Brain death 39  5 33  4 31  7
Brain death + HA 37  4 41  4 28  5
Mean arterial pressure (mm Hg)
Control 60  4 57  2 56  3
Brain death 58  3 50  2 45  4y
Brain death + HA 70  6 52  5 63  11
IL-6 (pg/mL)
Control 1.67  0.76 17.3  5.3 37.8  11y
Brain death 4.00  2.7 34.1  10 301  181y
Brain death + HA 3.60  1.0 22.0  8.0 94.6  20y
TNF (pg/mL)
Control 87.9  14.9 82.6  12.8 68.3  8.55
Brain death 60.3  4.40 95.9  20.4 106  13.1*,y
Brain death + HA 88.3  21.9 89.8  26.9 81.2  35.2
Figures are reported  standard errors of the mean. Boldface indicates statistically
significant results. HA, Hemoadsorption; PRSW, preload recruitable stroke work;
dP/dtmax, LV maximum change in pressure with time; IL, interleukin; TNF, tumor ne-
crosis factor. *P< .05 versus control (same time point). yP< .05 versus baseline
(same group). zP<.05 versus both other groups (same time point).
TABLE 2. Serum markers of noncardiac organ function over time
Baseline
3 h after
brain death
6 h after
brain death
Creatinine (mg/dL)
Control 0.90  0.1 1.12  0.1 1.10  0.1
Brain death 0.98  0.1 1.42  0.2 1.92  0.2*,y
Brain death + HA 0.85  0.1 1.36  0.2 1.54  0.2
BUN/creatinine
Control 9.3  0.7 9.4  0.9 12.0  2.1
Brain death 7.7  0.8 7.0  0.3 6.4  0.6
Brain death + HA 7.4  1.4 9.5  2.0 11.0  2.4
NGAL (ng/mL)
Control 145.5  20.8 137.0  20.3 163.2  24.4
Brain death 154.1  14.2 182.9  21.4 311.2  76.0y
Brain death + HA 120.7  16.2 153.6  28.5 152.2  38.4
AST (U/L)
Control 30.3  4.7 35.7  1.5 50.0  7.6
Brain death 24.0  1.2 30.6  2.2 46.4  11
Brain death + HA 30.3  5.6 35.8  6.1 54.8  12
ALT (U/L)
Control 32.3  5.4 28.7  6.2 28.0  6.0
Brain death 33.0  1.8 27.8  2.8 27.6  2.4
Brain death + HA 35.0  5.6 28.8  3.7 26.5  5.5
PaO2/FIO2
Control 498  10 477  37 443  48
Brain death 543  25 470  30 452  60
Brain death + HA 519  37 442  57 513  74
Figures are reported  standard errors of the mean. Boldface indicates statistically
significant results. HA, Hemoadsorption; BUN, blood urea nitrogen; NGAL, neutro-
phil gelatinase-associated lipocalin; AST, aspartate aminotransferase; ALT, alanine
aminotransferase; PaO2/FIO2, arterial oxygen tension/inspired oxygen fraction.
*P<.05 versus control (same time point). yP<.05 versus baseline (same group).
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Xanother measure of systolic function, was unchanged over
time within each group and unchanged at each time point
between groups (Table 1).
Effect of Cytokine Hemoadsorption on Diastolic Left
Ventricular Function
Diastolic LV function as reflected by tau is demonstrated
in Figure 3, B. There were no significant differences in tau218 The Journal of Thoracic and Cardiovascular Surgover time in the control group or brain deathþHA group.
However, in brain death, tau became significantly elevated
versus baseline at 5 hours and was significantly greater
than in both the other groups (and vs baseline) at 6 hours.
LV minimum change in pressure with time (dP/dtmin),
another measure of diastolic function, showed similar
trends: dP/dtmin was unchanged over time in both the con-
trol and brain deathþHA groups, whereas in the brain death
group it was significantly diminished versus baseline at
3 hours and significantly reduced versus baseline and versus
the other 2 groups at 6 hours (Table 1).Correlation Between Cytokine Expression and
Ventricular Function
Figure 4, A demonstrates the linear regression of TNF
concentration as a percentage of baseline versus PRSW as
a percentage of baseline. Figure 4, B demonstrates the rela-
tionship between the log IL-6 concentration as a percentage
of baseline and the PRSW. They both reveal negative slopes
that are significantly different from zero but have a loose
correlation with r2 of 0.3012 and 0.2111, respectively.
The correlation is more tenuous between TNF and IL-6
and tau (Figure 4, C and D).ery c January 2013
FIGURE 2. Effect of cytokine hemoadsorption (HA) on tumor necrosis factor (TNF) expression (A) and interleukin (IL)-6 expression (B).Brackets indicate
standard errors of the mean. Dashed vertical line indicates initiation of cytokine HA in the brain deathþHA group.
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XOther Hemodynamic Indices
Cardiac output was increased over time versus baseline in
the control group, unchanged in the brain deathþHA group,
and significantly reduced versus control at 6 hours in the
brain death group after induction of brain death (Table 1).
Mean arterial pressure was unchanged in the control and
brain deathþHA groups but was significantly diminished
in the brain death group at 6 hours. Differences in ejection
fraction were not statistically significant between groups.Effect of Hemoadsorption of Cytokines on Other
Organ Function
Table 2 demonstrates changes in serum markers of renal,
hepatic, and pulmonary function over time. Only differences
in renal indices were significant, with brain death
demonstrating progressively increasing creatinine and
NGAL. Doubling of serum creatinine (RIFLE injury)The Journal of Thoracic and Caoccurred in 0%, 67%, and 50% of animals in the control,
brain death, and brain deathþHA groups, respectively.
Postmortem Data
Myocardial water content was significantly greater in the
brain death group (79.2%  0.7%) compared with the
control group (74.1% 0.7%) and brain deathþHA group
(75.1%  1.07%, P< .001). Histologic analysis demon-
strated contraction band necrosis in 4 of 6 animals in the
brain dead group, 2 of 5 animals in the brain deadþHA
group, and 1 of 5 animals in the control group. Differences
were not statistically significant (Fisher exact test, 2-sided P
value ¼ .242).
DISCUSSION
This study demonstrates that extracorporeal, blood
purification using CytoSorb HA beginning 3 hours after
the induction of brain death attenuates both systolic andrdiovascular Surgery c Volume 145, Number 1 219
FIGURE 3. Effect of cytokine hemoadsorption (HA) on brain death–induced left ventricular (LV) systolic dysfunction (A) and LV diastolic dysfunction
(B). Brackets indicate standard errors of the mean. Dashed vertical line indicates initiation of cytokine HA in the brain deathþHA group. PRSW, Preload
recruitable stroke work.
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Xdiastolic indices of ventricular dysfunction, improves
cardiac output and mean arterial blood pressure, and
reduces myocardial edema in an open-chest porcine model.
Our data from the brain death group are consistent with pre-
vious work examining the effect of brain death on the same
indices of myocardial performance in pigs both in terms of
the extent of dysfunction and the time course of its develop-
ment.21 To our knowledge, this is the first time the CytoSorb
HA device has been used in the context of brain death in an
experimentally controlled setting where its impact on organ
function has been evaluated. The efficacy of cytokine HA
appeared more effective for TNF than for IL-6, where the
trend in diminished IL-6 expression in the brain dead treat-
ment group did not reach statistical significance; however,
the physiologic response to brain death is notoriously un-
predictable, resulting in large standard errors of the mean,
thus making demonstrations of differences between groups
challenging in a small preliminary study such as this one.
Regression analyses of individual cytokines with individ-
ual indices of ventricular function yielded a better albeit
loose correlation for systolic indices than for diastolic indi-
ces. However, because significant differences in contractil-
ity and ventricular compliance were observed between the220 The Journal of Thoracic and Cardiovascular Surgbrain death and the brain deathþHAgroups at 5 and 6 hours,
respectively, after the induction of brain death, and this is
the same time frame that significant differences in cytokine
expression began to appear between those 2 groups, it is
possible that cytokines measured and unmeasured exerted
a synergistic effect, as has been demonstrated.22 This hy-
pothesis is also supported by recent work in a low-
severity animal model of sepsis in which HA was shown
to improve organ function and survival despite a lack of ef-
fect of typical cytokines seen in sepsis.23 Elements of brain
death pathophysiology other than cytokine expression,
including hormonal and endocrine derangements, and
changes in regional perfusion and loading conditions due
to fluctuations in sympathetic neural activity all likely
conspired to negatively affect LV function. This is demon-
strated by impairment of PRSW in both groups subjected to
brain death (Figure 3, A, at time points 2 and 3) before de-
monstrable increases in cytokine concentrations; these
other factors likely contributed to diluting the correlation
between individual cytokine expression and observed
changes in function.
The effect of our intervention on systolic function was in-
consistent across parameters, with a significant effectery c January 2013
FIGURE 4. Correlation of cytokine concentration with indices of ventricular function. The load-independent index of contractility preload recruitable stroke
work (PRSW) is correlatedwith tumornecrosis factor [TNF] (A) and log interleukin [IL-6 ] (B).The diastolic relaxation constant tau is correlatedwith [TNF] (C)
and log [IL-6] (D). In all cases, the solid line indicates the linear regression and the dashed lines represent 95% confidence intervals. The equation for the linear
regression, the coefficient of determination, the F statistic, and the P value for the slope of the linear regression are reported for each analysis.
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Xdemonstrated when PRSW was evaluated but not when dP/
dtmax was used. This may be partially explained in that
PRSW is a load-independent index of contractility, whereas
dP/dtmax is not, and therefore potentially confounded by
changes in loading conditions known to occur in this setting.
The effect on diastolic indices wasmore consistent with syn-
chronous changes in tau and dP/dtmin. Significant differences
in myocardial edema determined postmortem are also con-
sistent with diminished ventricular compliance. Histologic
differences were not statistically significant, and the
presence of contraction band necrosis in 1 of the control an-
imals suggests inadequate preservation during the arrest or
the presence of preexisting underlying pathology, either of
which would confound our pathologic analysis. We were
somewhat surprised to observe increases in creatinine,which
do not typically occur acutely without pre-renal azotemia
(absent in this study); in addition,NGAL is a 20 to 25 kDpro-
tein and therefore is within the range of the HA filter (as are
the other serum markers measured). Given these concerns,
we are reluctant to draw conclusions about the effect of our
intervention on renal function despite previous studies that
demonstrated a renal-protective effect in a sepsis model.23The Journal of Thoracic and CaAlthough this study did not address the mechanism by
which increased cytokine expression might cause ventricu-
lar dysfunction, other studies have shown in both the intact
LV and isolated adult cardiac myocytes that alterations in
intracellular calcium homeostasis were present during the
systolic contraction sequence, resulting in diminished
inotropy and correlated with TNF concentration in a dose-
dependent and reversible fashion; furthermore, this effect
was preventable using anti-TNF antibodies.24 Other studies
in isolated hamster papillary muscles demonstrated that
TNF, IL-2, and IL-6 inhibited contractility in a concentra-
tion-dependent manner, an effect that was blocked by
a nitric oxide synthase inhibitor, suggesting that the
negative inotropic effect of these cytokines is mediated
through a myocardial nitric oxide synthase.11
Our method of attenuating brain death–induced ventricu-
lar dysfunction did not result in the same degree of preser-
vation as previous studies that were able to completely
prevent deterioration in ventricular function;21,25 however,
the former study21 required administration of a beta-
blocker before the induction of brain death and the latter
study25 required administration of steroids either before orrdiovascular Surgery c Volume 145, Number 1 221
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may diminish their clinical relevance.
Potentially confounding aspects of our experiment
include the possibility that the CytoSorb device inadver-
tently absorbed molecules in the same size range as cyto-
kines, such as catecholamines, cortisol, triiodothyronine,
and insulin. Although this possibility potentially confounds
our ability to isolate the effect of cytokines, it does not im-
pair our evaluation of the overall intervention. Another
potential confounder was the lack of a control group using
a mock extracorporeal circuit. However, had we used
a mock circuit in the brain death group, then differences be-
tween the 2 brain dead groups might be attributed to the in-
flammation resulting from the extracorporeal circuit itself,
not the pathophysiology of brain death; we were interested
in the impact of the overall intervention because this has the
greatest clinical relevance. Therefore, as a result, it is
possible that another aspect of the intervention was respon-
sible for the improvements in myocardial performance, for
example, it is conceivable that infusion of 200mL of normal
saline that was used to prime the circuit might have caused
increased intravascular oncotic pressure and diminished
myocardial edema, which could explain the differences in
function. Likewise, it is possible that another aspect of the
extracorporeal circuit unrelated to the CytoSorb filter,
such as heparin administration, might have affected
cytokine expression; therefore, in the absence of a mock
circuit, we cannot reliably link observed changes in cardiac
function or cytokine expression to the cytokine filter itself,
only the overall intervention. Finally, vasopressin adminis-
tration was used to prevent severe hypotension caused by
changes in loading conditions from inducing ischemia and
confounding our measurements of myocardial perfor-
mance; it was used in the same number of animals in the
2 brain dead groups and is unlikely to affect our indices
of ventricular function that are load-independent.
CONCLUSIONS
Although our data offer evidence of a beneficial effect of
the overall intervention on myocardial function, an effect
that generally correlates with observed differences in
cytokine expression, the mechanism of the effect remains
unresolved. In addition, the data do not show evidence of
improvement in function after initiating HA, only preven-
tion of further deterioration. Consequently, the organ donor
population might be a suboptimal application of this
therapy because it may be difficult to mobilize the resources
to initiate HA therapy in a meaningful time frame. Other po-
tentially more suitable applications might include
incorporating the HA filter in the cardiopulmonary bypass
circuit for routine or high-risk cardiac surgery procedures
to attenuate cardiopulmonary bypass–induced acute organ
dysfunction in the cardiac catheterization laboratory imme-
diately after percutaneous revascularization during an acute222 The Journal of Thoracic and Cardiovascular Surgmyocardial event to limit further cytokine-mediated dam-
age or after resuscitation from sudden death when surges
in inflammatory cytokines abound.
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XDiscussion
Dr Abbas Ardehali (Los Angeles, Calif). This is a relevant and
important study in the field of thoracic transplantation. It tries to
address the issue of why otherwise healthy donors have poor LV
function when the heart is offered for transplantation, and in
a broader sense it tries to address the issue of the donor shortage.
To put the issue of donor shortage in perspective, let me share
with you some numbers. There were 8100 consented kidney do-
nors last year in the United States, yet only 2300 of them were
heart donors, so approximately 70% of these consented donors
could not be heart donors. Although there are many explanations
for such discrepancies, such as distance, poor size, match, or donor
heart quality (eg, LV hypertrophy or coronary artery disease), an
important cohort is a group of donors who are otherwise healthy
and have no symptoms, but their heart is just not good. This study
tries to address this cohort and suggest that if you attach an extra-
corporeal circuit to them and remove these ‘‘evil humors,’’ the
heart is somehow going to turn out to be good and usable. This
is a relevant observation in that it can open up a new cohort of po-
tential heart donors.
I want to ask you 3 questions. The first refers to a mechanistic
explanation of the beneficial effects of HA. As you mentioned, the
filter that you used removes all molecules between 10 and 40 kDa,
but in addition to cytokines there aremany other circulating peptides
and nonprotein molecules that are removed or altered via exposure
with this membrane. The fact that you just lowered the level of TNF
and IL-6 does not necessarily establish a cause-and-effect relation-
ship but just anassociation.Canyouexpandon themechanismof the
beneficial effects of HA on the donor heart function?
Dr Rabkin. I could not agree with you more. This filter is not
specific to cytokines. In fact, the pores are sized between 20 and
50 kDa, but there is actually no way to prevent molecules even
smaller than 20 kDa from getting trapped into these pores, so
they are not specific to the inflammatory cytokines, and to try to
draw a direct link between the observed changes in function and
the changes in the cytokines that we noted would be inappropriate.
I think we can only say that the overall intervention of placing the
animals on the circuit is having some beneficial effect. This study
was not designed to investigate the mechanism, but we made some
attempts in the study to do various regression analyses to try to
draw a link between specific cytokines and specific parametersThe Journal of Thoracic and Caof ventricular function and found only a loose correlation. I think
the highest correlation coefficient was approximately 0.3, suggest-
ing that 30% of the observed effect could be attributed to a partic-
ular cytokine. There is a lot going on here in brain death
physiology other than the surge in cytokines. Certainly those
things are contributing to the changes in function that we have
seen, but to summarize, to directly address your question, I agree,
we cannot attribute the changes here to changes in the cytokine
concentration themselves.
Dr Ardehali. The second question is a practical one. As you
know, if you plan to do anything to a donor in any hospital in
the United States, you have to get the approval from up to 9 other
teams procuring other organs in addition to the organ procurement
agency. What do we know about the effect of HA on kidneys,
livers, lungs, cornea, and skin? The other relevant question is
can it be done in a small community hospital? And what are
some of the downsides of this technology?
Dr Rabkin. Those are excellent points. In terms of the first
question, the effects on other organ function, we looked at some
crude measurements of hepatic and renal and pulmonary function.
We did not find any changes in hepatic enzymes in any of the
groups, neither did we find any changes in the arterial oxygen ten-
sion of the animals, which was completely normal for all points af-
ter establishment of brain death. In terms of the renal function, we
did find that in the 2 brain death groups there was an increase in
creatinine over time, and that difference was statistically signifi-
cant for the brain death group, but we were skeptical there would
be such a significant change in creatinine in such a short time
frame. Also, in terms of the (RIFLE) criteria, which is a doubling
of the baseline creatinine, I think 3 and 4 animals were in the brain
death + HA group and the brain death alone group, respectively.
Again, wewere skeptical of that because in the absence of prerenal
azotemia we would not expect to see such a quick increase in cre-
atinine. Finally, we looked at NGAL, which is an early and sensi-
tive biomarker of renal injury, and we were able to show
a significant increase in NGAL in the brain death group, which
was not present in the brain death + HA group. However, just as
I was writing the article I thought to check the size of the NGAL
molecule, and it falls squarely in the range that the filter is picking
up, so I think you could attribute those differences to the fact that
the NGAL was getting caught up in the filter in the experimental
group. Therefore, we were not able to show any reliable effects
of this technology on other organ function.
In terms of the practicality of doing this and getting agreement
from the other teams, logistically it presents a lot of problems.
However, it is doable. John Kellum and colleagues at Pittsburgh
published an article that demonstrated the feasibility of using
this technology in a clinically relevant procurement scenario;
they placed brain-dead patients ineligible for organ transplant
for whatever reason on the HA circuit and showed that they could
bring down the cytokine concentrations and that it was possible to
do this. The equipment required is available in a community
hospital; I think it is nothing more than you would need for putting
patients on dialysis.
The only other comment I would make is that we set out to de-
velop a method of trying to rehabilitate hearts from the pathophys-
iology of brain death, and that is not really what we finally did. We
seemed to arrest the deterioration in function; however, we neverrdiovascular Surgery c Volume 145, Number 1 223
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of the required resources within 3 hours of establishing brain
death, which is probably not a realistic time frame in the commu-
nity to try to get a brain-dead patient into the hospital.224 The Journal of Thoracic and Cardiovascular SurgModerator. David, could you wrap it up please.
Dr Rabkin. Of course, so I am not sure if this is the best
application of this technology, but I think it is interesting enough
to pursue and might be applicable in other contexts.ery c January 2013
